Wyeth Backs Changes to Diet Drug Settlement
80541
NEW YORK, Jan 10  - Wyeth on Monday said it will  support changes in a nationwide legal settlement with users of  its "fen-phen" diet drugs, speeding up compensation to as many  as 40,000 people who say they were harmed by the recalled  medicines.
367403
Pharmaceutical firm Wyeth said Tuesday that the Food and Drug Administration granted fast-track status to its experimental cancer drug temsirolimus as an initial treatment for patients with advanced kidney cancer.
472457
Wyeth said on Tuesday that U.S.  regulators will review on an accelerated basis its experimental  drug temsirolimus as a first line treatment for advanced renal  cell carcinoma.
456666
Drugmaker Wyeth WYE.N said on Tuesday  it is in talks with plaintiffs' lawyers to develop a structure  to settle cases of users of recalled diet drugs "fen-phen" who  opted out of a nationwide legal settlement.
188330
Pharmaceutical firm Wyeth said Tuesday that the Food and Drug Administration granted fast-track status to its experimental cancer drug temsirolimus as an initial treatment for patients with advanced kidney ...
393841
Wyeth  on Thursday raised its  2006 profit forecast and said its recently approved Tygacil  antibiotic and three experimental medicines all could post  annual sales in the billions of dollars.
542334
Galvus, a diabetes drug produced by Novartis, has received a positive opinion from European health authorities after the firm made changes to prescribing recommendations due to liver safety issues.
6179
U.S. drugmaker Wyeth  said on Wednesday it was maintaining its profit forecast for 2007, but added that first-quarter earnings would exceed current Wall Street average estimates of 85 cents per share.
39352
Wyeth  said on Monday it will  sue Teva Pharmaceuticals USA  for alleged patent  infringement and said it received an approvable letter from U.S  regulators for bazedoxifene, a drug that helps prevent  post-menopausal osteoporosis.
733259
Drugmaker Wyeth  has reached a tentative framework with a group of plaintiffs' lawyers to settle nearly all remaining liability cases stemming from allegations that some of its diet drugs damaged heart valves, the Wall Street Journal reported on Tuesday, citing people familiar with the negotiations.
480440
California and 10 local prosecutors have reached a $1 million settlement with diet-pill maker Nutraquest Inc., which was accused of using deceptive techniques to sell weight-loss products that contained ephedra.
335428
Wyeth WYE.N on Monday reported a  fourth-quarter loss despite strong sales growth of its  prescription medicines, as it took another charge of $4.5  billion for costs related to its recalled fen-phen diet drugs.
73465
The difference between a pill and a capsule might not seem big, but it could result in hundreds of millions of dollars in lost sales for Wyeth's top drug.
477384
Wyeth, the largest maker of hormone-replacement medicines used during menopause, won dismissal of a lawsuit in Minnesota linking its Premarin and Prempro drugs to breast cancer.
439931
Wyeth said on Tuesday that U.S. regulators will review on an accelerated basis its experimental drug temsirolimus as a first line treatment for advanced renal cell carcinoma.
669356
Unhappy customers who sued "Dr. Phil" McGraw over his now discontinued Shape Up! diet plan have reached a $10.5 million settlement agreement with the TV psychologist, an attorney for the plaintiffs said.
357820
NEW DELHI, DECEMBER 27: The Centre brought into effect key changes to its patent law on Monday to cover a range of products from drugs and chemicals to mobile phone and computer software, in line with commitments to WTO.